Hangzhou Diagens Biotechnology Co., Ltd./ADR (HGZDY)
OTC: HGZDY · CIK 0002128813 · United States
Every official Hangzhou Diagens Biotechnology Co., Ltd./ADR filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open HGZDY filings
Hangzhou Diagens Biotechnology Co., Ltd./ADR documents
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 10-K 2026HGZDY 10-K 2026: annual report for fiscal 2026
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 10-K 2025HGZDY 10-K 2025: annual report for fiscal 2025
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 10-K 2024HGZDY 10-K 2024: annual report for fiscal 2024
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 10-K 2023HGZDY 10-K 2023: annual report for fiscal 2023
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 10-K 2022HGZDY 10-K 2022: annual report for fiscal 2022
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 10-Q 2026HGZDY 10-Q 2026: quarterly report for fiscal 2026
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 10-Q 2025HGZDY 10-Q 2025: quarterly report for fiscal 2025
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 10-Q 2024HGZDY 10-Q 2024: quarterly report for fiscal 2024
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 10-Q 2023HGZDY 10-Q 2023: quarterly report for fiscal 2023
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 10-Q 2022HGZDY 10-Q 2022: quarterly report for fiscal 2022
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 8-K 2026HGZDY 8-K 2026: current report for fiscal 2026
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 8-K 2025HGZDY 8-K 2025: current report for fiscal 2025
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 8-K 2024HGZDY 8-K 2024: current report for fiscal 2024
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 8-K 2023HGZDY 8-K 2023: current report for fiscal 2023
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 8-K 2022HGZDY 8-K 2022: current report for fiscal 2022
- Hangzhou Diagens Biotechnology Co., Ltd./ADR DEF 14A 2026HGZDY DEF 14A 2026: proxy statement for fiscal 2026
- Hangzhou Diagens Biotechnology Co., Ltd./ADR DEF 14A 2025HGZDY DEF 14A 2025: proxy statement for fiscal 2025
- Hangzhou Diagens Biotechnology Co., Ltd./ADR DEF 14A 2024HGZDY DEF 14A 2024: proxy statement for fiscal 2024
- Hangzhou Diagens Biotechnology Co., Ltd./ADR DEF 14A 2023HGZDY DEF 14A 2023: proxy statement for fiscal 2023
- Hangzhou Diagens Biotechnology Co., Ltd./ADR DEF 14A 2022HGZDY DEF 14A 2022: proxy statement for fiscal 2022
- Hangzhou Diagens Biotechnology Co., Ltd./ADR Form 4 2026HGZDY Form 4 2026: insider trading filing for fiscal 2026
- Hangzhou Diagens Biotechnology Co., Ltd./ADR Form 4 2025HGZDY Form 4 2025: insider trading filing for fiscal 2025
- Hangzhou Diagens Biotechnology Co., Ltd./ADR Form 4 2024HGZDY Form 4 2024: insider trading filing for fiscal 2024
- Hangzhou Diagens Biotechnology Co., Ltd./ADR Form 4 2023HGZDY Form 4 2023: insider trading filing for fiscal 2023
- Hangzhou Diagens Biotechnology Co., Ltd./ADR Form 4 2022HGZDY Form 4 2022: insider trading filing for fiscal 2022
- Hangzhou Diagens Biotechnology Co., Ltd./ADR S-1 2026HGZDY S-1 2026: registration statement for fiscal 2026
- Hangzhou Diagens Biotechnology Co., Ltd./ADR S-1 2025HGZDY S-1 2025: registration statement for fiscal 2025
- Hangzhou Diagens Biotechnology Co., Ltd./ADR S-1 2024HGZDY S-1 2024: registration statement for fiscal 2024
- Hangzhou Diagens Biotechnology Co., Ltd./ADR S-1 2023HGZDY S-1 2023: registration statement for fiscal 2023
- Hangzhou Diagens Biotechnology Co., Ltd./ADR S-1 2022HGZDY S-1 2022: registration statement for fiscal 2022
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 13F 2026HGZDY 13F 2026: institutional holdings for fiscal 2026
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 13F 2025HGZDY 13F 2025: institutional holdings for fiscal 2025
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 13F 2024HGZDY 13F 2024: institutional holdings for fiscal 2024
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 13F 2023HGZDY 13F 2023: institutional holdings for fiscal 2023
- Hangzhou Diagens Biotechnology Co., Ltd./ADR 13F 2022HGZDY 13F 2022: institutional holdings for fiscal 2022
More companies